Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene

EU orphan designation number: EU/3/12/957   
Active ingredient: Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene
Indication: Treatment of X-linked chronic granulomatous disease
Sponsor: Généthon
1 bis rue de l’internationale, F-91000 Evry, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Centralised Orphan - Designation EMA/OD/118/11 (2012)883 of 09/02/2012